Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44-Reference-Cited by-同舟云学术

Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44

Published:2019-04-23 Issue:6 Volume:16 Page:2481-2493
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Spadea Alice¹²³,Rios de la Rosa Julio Manuel¹²⁴,Tirella Annalisa¹²,Ashford Marianne B.²⁵,Williams Kaye J.¹³,Stratford Ian J.¹²³^ORCID,Tirelli Nicola¹²⁶,Mehibel Manal¹⁷

Affiliation:

1. Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester and Manchester Academic Health Science Centre, Stopford Building, Manchester M13 9PT, U.K.

2. Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, North West Centre of Advanced Drug Delivery (NoWCADD), Stopford Building, Manchester M13 9PT, U.K.

3. Manchester Cancer Research Centre, The University of Manchester, 555 Wilmslow Road, Manchester M20 4GJ, U.K.

4. BiOncoTech Therapeutics S.L., Science 2 Business Foundation, C/ Santiago Grisolia 2 Tres Cantos, Madrid 28760, Spain

5. Pharmaceutical Sciences, Innovative Medicines Biotech Unit, AstraZeneca, Macclesfield SK10 2NA, U.K.

6. Laboratory of Polymers and Biomaterials, Fondazione Istituto Italiano di Tecnologia, 16163 Genova, Italy

7. Department of Radiation Oncology, Stanford University, Stanford, California 94305-5847, United States

Funder

AstraZeneca

Engineering and Physical Sciences Research Council

University of Manchester

Breast Cancer Now

Wellcome Trust

Cancer Research UK

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.9b00083

Reference84 articles.

1. Emerging Frontiers in Drug Delivery

2. Hyaluronan: from extracellular glue to pericellular cue

3. Application of hyaluronic acid as carriers in drug delivery

4. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives

5. Receptor-Targeted Drug Delivery and the (Many) Problems We Know of: The Case of CD44 and Hyaluronic Acid

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted codelivery of doxorubicin and oleanolic acid by reduction responsive hyaluronic acid-based prodrug nano-micelles for enhanced antitumor activity and reduced toxicity;International Journal of Biological Macromolecules;2024-10

2. Synthesis and application of multifunctional magnetic mesoporous nanomaterials with redox reaction and NIR response in tumor treatment;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-08

3. FOXM1 Aptamer-Polyethylenimine Nanoplatform Coated With Hyaluronic Acid And AS1411 Aptamer For Dual-Targeted Delivery of Doxorubicin And Synergistic Treatment of Tumor Cells;Journal of Pharmaceutical Sciences;2024-08

4. Fine-tuning of liposome integrity for differentiated transcytosis and enhanced antitumor efficacy;Journal of Controlled Release;2024-08

5. CD44 and its implication in neoplastic diseases;MedComm;2024-05-23